General Information


DRAVP ID  DRAVPe01989

Peptide Name   None

Sequence  PLSPPLRNTHPQAMQWNSTTF

Sequence Length  21

UniProt ID  O92921 

Taxon ID  None

Source  Synthetic construct

Validation   Experimentally Validated



Origin Information


Gene Name/ID  Not Available

GenBank  Not Available

Amino Acid position  Not Available

Domain Accession ID  Not Available

Nucleotide sequence ID  Not Available

Molecular Type  Not Available

Chromosomal Position  Not Available



Activity Information


Target Organism  HBV

Assay  Scintillation count

Activity 

  • [Ref.12469306]Hepatitis B virus(HBV): inhibition of the association of L-HBsAg with HBcAg(IC50=30±1 μM).

Hemolytic Activity  No hemolysis information or data found in the reference(s) presented in this entry

Cytotoxicity 

  • No cytotoxicity information or data found in the reference(s) presented in this entry

Binding Target  core antigen (HBcAg)(Viral assembly)

Mechanism  During HBV morphogenesis, both the PreS and S domains of L-HBsAg form docking sites for the viral nucleocapsids. Thus, a compound that disrupts the interaction between the L-HBsAg and nucleocapsids could serve as a therapeutic agent against the virus based upon inhibition of morphogenesis. Peptide inhibits the association of L-HBsAg with core antigen (HBcAg).



Structure Information


PDB ID  None

Predicted Structure Download  No predicted structure available

Linear/Cyclic  Linear

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Stereochemistry  L



Physicochemical Information


Formula  C108H163N31O31S

Absent amino acids  CDEGIKVY

Common amino acids  P

Mass  2423.73

Pl  10.18

Basic residues  2

Acidic residues  0

Hydrophobic residues  5

Net charge  2

Boman Index  -3914

Hydrophobicity  -88.57

Aliphatic Index  41.9

Half Life 

  •     Mammalian:>20 hour
  •     Yeast:>20 hour
  •     E.coli:?

Extinction Coefficient cystines  5500

Absorbance 280nm  275

Polar residues  7



Literature Information


Literature 1

Title   Inhibition of hepatitis B virus assembly with synthetic peptides derived from the viral surface and core antigens.

Pubmed ID   12469306

Reference   J Gen Appl Microbiol. 2002 Apr;48(2):103-7.

Author   Tan WS.

DOI   10.2323/jgam.48.103